Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Before NPM1-ALK-containing ALCL cells progress to unrestrain...

Class:IdSummation:9850830
_displayNameBefore NPM1-ALK-containing ALCL cells progress to unrestrain...
_timestamp2023-10-12 18:30:03
created[InstanceEdit:9850804] Rothfels, Karen, 2023-10-12
textBefore NPM1-ALK-containing ALCL cells progress to unrestrained proliferative growth and transformation, they appear to be subject to an early phase of NPM1-ALK-induced senescence that depends on cell cycle arrest rather than cell death (Martinelli et al, 2011; McDuff et al, 2011). Independent studies have identified CDKN2A (p16INK4a) and/or TP53/RB1 as mediators of this pre-transformation arrest in NPM1-ALK cell lines and mouse models. Cells are characterized by low proliferation rates, low incorporation of BrDU, expression of senescence-associated beta galactosidase and accumulation of hypophosphorylated RB1 protein (the form that promotes cell cycle arrest) (Martinelli et al, 2011; McDuff et al, 2011). The Martinelli study identified CDKN2A/p16INK4a as a critical effector of NPM1-ALK mediated cell cycle arrest as the block on proliferation was abolished in a CDKN2A/p16INK4a negative background and tumor development in CDKN2A/p16INK4a- transgenic mice was accelerated. Consistent with this, CDKN2A/p16INK4a expression is upregulated in an NPM1-ALK-, STAT3- and JMJD3- (a H3K27 histone demethylase) dependent manner in MEFs expressing NPM1-ALK (Martinelli et al, 2011). In contrast, although CDKN2A/p16INK4a was implicated in cell cycle arrest in the McDuff study, deletion of this locus was not sufficient to relieve the block on proliferation in NPM1-ALK cells. Instead, the cell cycle arrest was shown to depend on the TP53 and RB1 pathways - paradoxically in the absence of TP53 stabilization or CDKN1A/p21 induction (McDuff et al, 2011).
(summation)[BlackBoxEvent:9851127] NPM1-ALK-dependent repression of pRB phosphorylation [Homo sapiens]
[Change default viewing format]
No pathways have been reviewed or authored by Before NPM1-ALK-containing ALCL cells progress to unrestrain... (9850830)